Characteristics | Survivors, n = 33 | Dead, n = 24 | p |
---|---|---|---|
Women, n (%) | 29 (87.9) | 20 (83.3) | 0.709† |
Age, yrs | 23.0 (17–29) | 23.5 (18.5–32.5) | 0.910 |
Disease duration of SLE | 1.23 (0.08–3.6) | 0.3 ± (0.07–2.5) | 0.526 |
WBC, 103/ml | 7.7 (5.6–13) | 8.8 (5.7–13.0) | 0.859 |
Lymphocytes, 103/ml | 0.77 (0.5–1.02) | 0.57 (0.45–0.90) | 0.2478 |
Creatinine, mg/dl | 0.75 (0.5–1.5) | 2.0 (0.9–2.9) | 0.012 |
Platelets | 205 (133–296) | 123.5 (73–170.5) | 0.016 |
APACHE II | 16.0 (12–21) | 23.0 (16–24) | 0.003 |
Hemoglobin drop | 3.0 (2.4–3.9) | 3.0 (2.2–4.0) | 0.7895 |
CRP, mg/dl | 9.3 (0.9–16.4) | 14.6 (1.6–20.4) | 0.5486 |
MV, n (%) | 20 (60.6) | 23 (95.8) | 0.002 |
Hemoptysis, n (%) | 19 (19.1) | 14 (58.3) | 0.954 |
CYC, n (%) | 17 (51.5) | 11 (45.8) | 0.672 |
Infection, n (%) | 9 (27.3) | 13 (54.2) | 0.039 |
IVIG, n (%) | 3 (9.1) | 1 (4.2) | 0.300† |
RTX, n (%) | 0 (0.0) | 3 (12.5) | 0.069† |
↵† Fisher’s exact test, otherwise chi-square. WBC: white blood cells; CRP: C-reactive protein; MV: mechanical ventilation; CYC: cyclophosphamide; IVIG: intravenous immunoglobulin; RTX: rituximab; SLE: systemic lupus erythematosus; APACHE: Acute Physiology and Chronic Health Evaluation score.